BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 70 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $782,000 | -9.0% | 9,766 | -38.7% | 0.90% | -15.8% |
Q4 2018 | $859,000 | -28.7% | 15,932 | +3.2% | 1.07% | +16.3% |
Q3 2018 | $1,205,000 | +94.0% | 15,437 | +57.7% | 0.92% | +84.2% |
Q2 2018 | $621,000 | -35.2% | 9,789 | -6.3% | 0.50% | -51.6% |
Q1 2018 | $958,000 | +26.7% | 10,446 | +4.3% | 1.04% | +18.8% |
Q4 2017 | $756,000 | -49.0% | 10,020 | -52.9% | 0.87% | -38.0% |
Q3 2017 | $1,481,000 | +56.9% | 21,252 | +14.1% | 1.40% | +10.8% |
Q2 2017 | $944,000 | +49.8% | 18,622 | +18.2% | 1.27% | +65.3% |
Q1 2017 | $630,000 | +111.4% | 15,748 | +48.1% | 0.77% | +94.2% |
Q4 2016 | $298,000 | +8.4% | 10,635 | +14.8% | 0.40% | -3.2% |
Q3 2016 | $275,000 | -32.3% | 9,262 | -53.8% | 0.41% | -38.6% |
Q2 2016 | $406,000 | +19.8% | 20,049 | +6.7% | 0.66% | +20.3% |
Q1 2016 | $339,000 | -28.6% | 18,788 | +4.1% | 0.55% | -29.1% |
Q4 2015 | $475,000 | +118.9% | 18,052 | +77.8% | 0.78% | +137.5% |
Q3 2015 | $217,000 | +11.3% | 10,154 | +38.1% | 0.33% | +19.7% |
Q2 2015 | $195,000 | – | 7,350 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |